Neuropharmacology:
Neuropharmacology is the study of how drugs modify cellular function in the nervous system, and the neural mechanisms through which they oppress behavior.There are two main branches of neuropharmacology: behavioral and molecular. Behavioral neuropharmacology concentrate on the study of how drugs affect human behavior (neuropsychopharmacology), including the study of how drug dependence and addiction influence the human brain.Molecular neuropharmacology contains the study of neurons and their neurochemical interactions, with the overall goal of developing drugs that have beneficial effects on neurological function.
Neurochemistry:
Neurochemistry is the study of chemicals, involving neurotransmitters and other molecules such as psychopharmaceuticals and neuropeptides, that control and influence the physiology of the nervous system.
Important Alert:
X
Title : Neural nanomedicine: Fighting stroke, improving stem cell delivery, healing nerves and using artificial intelligence
Thomas J Webster, Interstellar Therapeutics, United States
Title : The therapeutic value of the design and development of neurophysics therapy’s psychophysical ‘Grids’ to afford reliable point to point measurements in space/time of the initial conditions of a patients perception, action and cognition and the correction/modulation of sensory perceptual errors in the treatment of chronic pain CRPS and other complex
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : 3DYNAFS-MBAFUS: A virtual lab of microbubble-amplified focused ultrasound for noninvasive treatments of neurodisorders
Jingsen Ma, Dynaflow, Inc, United States
Title : Human understanding and machine intelligence: A systems neuroscience perspective
Yan M Yufik, Virtual Structures Research, Inc, United States
Title : Treatment of chronic muscle spasm and pain with the CMECD® procedure
Roger H Coletti, Interventional Health, PA, United States
Title : Artificial Intelligence/Machine Learning (AI/ML) models could predict the risks for brain tumors months ahead of diagnosis using routine blood markers
Raj Gopalan, BSRM Consulting, United States